NCT02616679View on ClinicalTrials.gov

Cognitive Detection of Preclinical AD: Validation Using Biomarkers

CompletedOBSERVATIONAL
Enrollment

81

Participants

Timeline

Start Date

January 5, 2016

Primary Completion Date

August 12, 2020

Study Completion Date

August 12, 2020

Conditions
Mild Cognitive Impairment
Trial Locations (1)

10016

NYU Langone Medical Center, New York

All Listed Sponsors
collaborator

Janssen Scientific Affairs, LLC

INDUSTRY

lead

NYU Langone Health

OTHER

NCT02616679 - Cognitive Detection of Preclinical AD: Validation Using Biomarkers | Biotech Hunter | Biotech Hunter